[HTML][HTML] Time to review the role of surrogate end points in health policy: state of the art and the way forward
The efficacy of medicines, medical devices, and other health technologies should be proved
in trials that assess final patient-relevant outcomes such as survival or morbidity. Market …
in trials that assess final patient-relevant outcomes such as survival or morbidity. Market …
[PDF][PDF] 2016 ESC/EAS guidelines for the management of dyslipidaemias
AL Catapano, I Graham, G De Backer… - Polish Heart …, 2016 - journals.viamedica.pl
5.1. Wpływ stylu życia na stężenie cholesterolu całkowitego i stężenie cholesterolu frakcji
lipoprotein o małej gęstości................................ 1259 5.2. Wpływ stylu życia na stężenie …
lipoprotein o małej gęstości................................ 1259 5.2. Wpływ stylu życia na stężenie …
[HTML][HTML] More use of peritoneal dialysis gives significant savings: a systematic review and health economic decision model
E Pike, V Hamidi, T Ringerike, T Wisloff… - Journal of clinical …, 2017 - ncbi.nlm.nih.gov
Background Patients with end-stage renal disease (ESRD) are in need of renal replacement
therapy as dialysis and/or transplantation. The prevalence of ESRD and, thus, the need for …
therapy as dialysis and/or transplantation. The prevalence of ESRD and, thus, the need for …
[PDF][PDF] 2016 ESC/EAS guidelines for the management of dyslipidaemias
MT Cooney, E Bruckert, A Cordero, A Corsini… - European Heart …, 2016 - iris.unime.it
The content of these European Society of Cardiology (ESC) and European Atherosclerosis
Society Guidelines has been published for personal and educational use only. No …
Society Guidelines has been published for personal and educational use only. No …
[PDF][PDF] Wytyczne ESC/EAS dotyczace leczenia zaburzeń lipidowych w 2016 roku
AL Catapano, I Graham, G De Backer, O Wiklund… - Kardiologia …, 2016 - air.unimi.it
5.1. Wpływ stylu życia na stężenie cholesterolu całkowitego i stężenie cholesterolu frakcji
lipoprotein o małej gęstości................................ 1259 5.2. Wpływ stylu życia na stężenie …
lipoprotein o małej gęstości................................ 1259 5.2. Wpływ stylu życia na stężenie …
Variation in hypertension clinical practice guidelines: a global comparison
R Philip, T Beaney, N Appelbaum, CR Gonzalvez… - BMC medicine, 2021 - Springer
Background Hypertension is the largest single contributor to the global burden of disease,
affecting an estimated 1.39 billion people worldwide. Clinical practice guidelines (CPGs) …
affecting an estimated 1.39 billion people worldwide. Clinical practice guidelines (CPGs) …
Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension
M Dorenkamp, K Bonaventura, AW Leber… - European Heart …, 2013 - academic.oup.com
Aims Recent studies have demonstrated the safety and efficacy of catheter-based renal
sympathetic denervation (RDN) for the treatment of resistant hypertension. We aimed to …
sympathetic denervation (RDN) for the treatment of resistant hypertension. We aimed to …
Cost-effectiveness of incentives for physical activity in coronary heart disease in Germany: pre-trial health economic model of a complex intervention following the new …
D Mohebbi, K Ogurtsova, J Dyczmons… - BMJ Open Sport & …, 2024 - bmjopensem.bmj.com
Objectives The German Incentives for Physical Activity in Cardiac Patients trial is a three-
arm, randomised controlled trial for secondary prevention of coronary heart disease (CHD) …
arm, randomised controlled trial for secondary prevention of coronary heart disease (CHD) …
Economic evaluation of lipid lowering with PCSK9 inhibitors in patients with familial hypercholesterolemia: methodological aspects
T Wisløff, LJ Mundal, K Retterstøl, J Igland… - Atherosclerosis, 2019 - Elsevier
Background and aims Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have
proved to reduce low density lipoprotein cholesterol levels in numerous clinical trials. In two …
proved to reduce low density lipoprotein cholesterol levels in numerous clinical trials. In two …
Educational attainment and differences in relative survival after acute myocardial infarction in Norway: a registry-based population study
ST Klitkou, KR Wangen - BMJ open, 2017 - bmjopen.bmj.com
Background Although there is a broad societal interest in socioeconomic differences in
survival after an acute myocardial infarction, only a few studies have investigated how such …
survival after an acute myocardial infarction, only a few studies have investigated how such …